WESPAC Advisors »

Vertex Pharmaceuticals Incorporated shares owned by WESPAC Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by WESPAC Advisors from 13F filings

Historical chart of WESPAC Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by WESPAC Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by WESPAC Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $280k 670 418.01
2023-12-31 $273k 670 406.89
2023-09-30 $233k 670 347.74
2019-03-31 $618k 3.4k 183.87
2018-09-30 $254k 1.3k 192.57
2018-03-31 $867k 5.3k 162.94

More positions owned by WESPAC Advisors

Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Us Aer Def Etf (ITA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Vaneck Etf Trust Clo Etf (CLOI)
Owl Rock Capital Corporation (OBDC)
Qualcomm (QCOM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr U.s. Med Dvc Etf (IHI)
Eli Lilly & Co. (LLY)

View all positions for WESPAC Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated